Literature DB >> 5477666

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

A Breslow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5477666      PMCID: PMC1397358          DOI: 10.1097/00000658-197011000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  6 in total

1.  Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults.

Authors:  N LANE; R LATTES; J MALM
Journal:  Cancer       Date:  1958 Sep-Oct       Impact factor: 6.860

2.  Malignant melanoma; clinical and pathologic analysis of 93 cases. Is prophylactic lymph node dissection indicated?

Authors:  R H LUND; M IHNEN
Journal:  Surgery       Date:  1955-10       Impact factor: 3.982

3.  Malignant melanoma of the skin; report of 341 cases treated during the years 1929-1943.

Authors:  B SYLVEN
Journal:  Acta radiol       Date:  1949-07-31       Impact factor: 1.990

4.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

Authors:  W H Clark; L From; E A Bernardino; M C Mihm
Journal:  Cancer Res       Date:  1969-03       Impact factor: 12.701

5.  Clinical study of forty-nine patients with malignant melanoma.

Authors:  J A Lehman; F S Cross; D G Richey
Journal:  Cancer       Date:  1966-05       Impact factor: 6.860

6.  The surgical management of patients with melanoma.

Authors:  H B Lehr; H P Royster; H T Enterline; S I Askovitz
Journal:  Plast Reconstr Surg       Date:  1967-11       Impact factor: 4.730

  6 in total
  320 in total

1.  Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Authors:  R D Ramirez; S D'Atri; E Pagani; T Faraggiana; P M Lacal; R S Taylor; J W Shay
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Improving Melanoma Path Reports: the Importance of Histopathological Parameters in Diagnosis of Cutaneous Melanoma.

Authors:  Alina Mariana Avram; Olga Dana Simionescu; Mariana Costache; Mariana Grigore
Journal:  Maedica (Buchar)       Date:  2015-09

3.  Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).

Authors:  H J Wanebo; J G Fortner; J Woodruff; B MacLean; E Binkowski
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

4.  Effects of motion on optical properties in the spatial frequency domain.

Authors:  John Quan Nguyen; Rolf B Saager; David J Cuccia; Kristen M Kelly; James Jakowatz; David Hsiang; Anthony J Durkin
Journal:  J Biomed Opt       Date:  2011-12       Impact factor: 3.170

5.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

6.  Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.

Authors:  Emily Z Keung; Jeffrey E Gershenwald
Journal:  J Natl Cancer Inst       Date:  2020-09-01       Impact factor: 13.506

7.  Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

Authors:  T J de Vries; P H Quax; M Denijn; K N Verrijp; J H Verheijen; H W Verspaget; U H Weidle; D J Ruiter; G N van Muijen
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  [Regression in malignant melanoma. Definition, etiopathogenesis, morphology and differential diagnosis].

Authors:  B E Paredes
Journal:  Pathologe       Date:  2007-11       Impact factor: 1.011

10.  TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells.

Authors:  Michele B Weiss; Ethan V Abel; Melanie M Mayberry; Kevin J Basile; Adam C Berger; Andrew E Aplin
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.